StonvexLoading…
StonvexStonvexStonvexCore line items from CNTB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $169.00K | $64.00K | $64.00K | $48.00K |
Operating Income | $-19.61M | $-58.07M | $-42.55M | $-24.87M |
Net Income | $-19.40M | $-55.48M | $-40.37M | $-12.90M |
EPS (Diluted) | $-0.34 | $-1.00 | $-0.73 | $-0.42 |
Total Assets | $60.07M | $56.08M | $67.36M | $82.72M |
Total Liabilities | $17.44M | $14.10M | $11.99M | $11.38M |
Cash & Equivalents | $46.03M | $38.34M | $37.84M | $40.63M |
Free Cash Flow OCF − CapEx | $-16.00M | $-51.64M | $-40.37M | $-22.93M |
Shares Outstanding | 62.71M | 56.44M | 55.79M | 55.58M |